DE60101223T2 - Antivirale pyrimidin nucleoside derivate - Google Patents

Antivirale pyrimidin nucleoside derivate Download PDF

Info

Publication number
DE60101223T2
DE60101223T2 DE60101223T DE60101223T DE60101223T2 DE 60101223 T2 DE60101223 T2 DE 60101223T2 DE 60101223 T DE60101223 T DE 60101223T DE 60101223 T DE60101223 T DE 60101223T DE 60101223 T2 DE60101223 T2 DE 60101223T2
Authority
DE
Germany
Prior art keywords
alkyl
group
compound according
halogens
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60101223T
Other languages
German (de)
English (en)
Other versions
DE60101223D1 (de
Inventor
Christopher Whitchurch MCGUIGAN
Jan Balzarini
Erik De Clercq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rega Foundation
University College Cardiff Consultants Ltd
Cardiff University
Original Assignee
Rega Foundation
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rega Foundation, University College Cardiff Consultants Ltd, Cardiff University filed Critical Rega Foundation
Publication of DE60101223D1 publication Critical patent/DE60101223D1/de
Application granted granted Critical
Publication of DE60101223T2 publication Critical patent/DE60101223T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60101223T 2000-05-09 2001-05-08 Antivirale pyrimidin nucleoside derivate Expired - Fee Related DE60101223T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0011203.7A GB0011203D0 (en) 2000-05-09 2000-05-09 Chemical compounds
GB0011203 2000-05-09
PCT/GB2001/002004 WO2001085749A1 (en) 2000-05-09 2001-05-08 Anti-viral pyrimidine nucleoside analogues

Publications (2)

Publication Number Publication Date
DE60101223D1 DE60101223D1 (de) 2003-12-18
DE60101223T2 true DE60101223T2 (de) 2004-09-02

Family

ID=9891276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60101223T Expired - Fee Related DE60101223T2 (de) 2000-05-09 2001-05-08 Antivirale pyrimidin nucleoside derivate

Country Status (14)

Country Link
US (1) US7019135B2 (https=)
EP (1) EP1280813B1 (https=)
JP (1) JP2003532735A (https=)
AT (1) ATE254132T1 (https=)
AU (1) AU780879B2 (https=)
CA (1) CA2406633A1 (https=)
DE (1) DE60101223T2 (https=)
DK (1) DK1280813T3 (https=)
ES (1) ES2210153T3 (https=)
GB (1) GB0011203D0 (https=)
NZ (1) NZ521877A (https=)
PT (1) PT1280813E (https=)
TR (1) TR200302313T4 (https=)
WO (1) WO2001085749A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
CA2317505C (en) 1998-01-23 2011-01-04 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
AU774492B2 (en) 1999-07-22 2004-07-01 Celmed Oncology (Usa) Inc. Methods for treating therapy-resistant tumors
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
GB0009486D0 (en) 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
HUE033832T2 (en) 2002-11-15 2018-01-29 Idenix Pharmaceuticals Llc 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
GB0609178D0 (en) * 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
EP2691409B1 (en) 2011-03-31 2018-02-21 Idenix Pharmaceuticals LLC. Compounds and pharmaceutical compositions for the treatment of viral infections
GB201111779D0 (en) * 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
TW201329096A (zh) 2011-09-12 2013-07-16 Idenix Pharmaceuticals Inc 經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
US8507460B2 (en) 2011-10-14 2013-08-13 Idenix Pharmaceuticals, Inc. Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
WO2013177188A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphoramidate prodrugs for hcv infection
CA2873315A1 (en) 2012-05-22 2013-11-28 Idenix Pharamaceuticals, Inc. D-amino acid compounds for liver disease
SG11201407336PA (en) 2012-05-25 2015-03-30 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
KR102001280B1 (ko) 2012-10-08 2019-07-17 아이데닉스 파마슈티칼스 엘엘씨 Hcv 감염에 대한 2'-클로로 뉴클레오시드 유사체
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
EP2935304A1 (en) 2012-12-19 2015-10-28 IDENIX Pharmaceuticals, Inc. 4'-fluoro nucleosides for the treatment of hcv
US9309275B2 (en) 2013-03-04 2016-04-12 Idenix Pharmaceuticals Llc 3′-deoxy nucleosides for the treatment of HCV
US9339541B2 (en) 2013-03-04 2016-05-17 Merck Sharp & Dohme Corp. Thiophosphate nucleosides for the treatment of HCV
WO2014160484A1 (en) 2013-03-13 2014-10-02 Idenix Pharmaceuticals, Inc. Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
EP2981542B1 (en) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluoro nucleosides for the treatment of hcv
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
WO2015017713A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
WO2015161137A1 (en) 2014-04-16 2015-10-22 Idenix Pharmaceuticals, Inc. 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) * 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
GB9708611D0 (en) * 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Also Published As

Publication number Publication date
DE60101223D1 (de) 2003-12-18
TR200302313T4 (tr) 2004-01-21
CA2406633A1 (en) 2001-11-15
ES2210153T3 (es) 2004-07-01
PT1280813E (pt) 2004-03-31
GB0011203D0 (en) 2000-06-28
EP1280813A1 (en) 2003-02-05
NZ521877A (en) 2004-11-26
AU780879B2 (en) 2005-04-21
WO2001085749A1 (en) 2001-11-15
US7019135B2 (en) 2006-03-28
EP1280813B1 (en) 2003-11-12
JP2003532735A (ja) 2003-11-05
US20030176370A1 (en) 2003-09-18
AU5494501A (en) 2001-11-20
ATE254132T1 (de) 2003-11-15
DK1280813T3 (da) 2004-03-22

Similar Documents

Publication Publication Date Title
DE60101223T2 (de) Antivirale pyrimidin nucleoside derivate
DE69806919T2 (de) Antivirale pyrimidin-nukleosid-analogen
DE60102293T2 (de) Antivirale pyrimidin-nukleosid-analogen
DE69825780T2 (de) Adenosin a1-rezeptor agonisten
EP0538194B1 (de) Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
EP0545966B1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE4204031A1 (de) Neue lipidphosphonsaeure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel
DE4204032A1 (de) Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
DE4223438A1 (de) Cyclische oligonucleotidphosphorthioate
DD296687A5 (de) Nucleosid-derivate und deren verwendung als arzneimittel
NZ535246A (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
WO1996032403A2 (de) Neue cytosin- und cytidinderivate
WO1996025421A1 (de) Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel
DE602004001047T2 (de) Phospholipidester von Clofarabin
WO2009129798A2 (de) Di- und triphosphat-prodrugs, insbesondere nukleosiddi- und -triphosphat-prodrugs
DE69533856T2 (de) L-pyranosyl-nukleoside
EP0507188A1 (de) Substituierte 2',3'-Didesoxy-5-trifluormethyluridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
MXPA99009965A (en) Anti-viral pyrimidine nucleoside analogues

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee